Posted by Michael Wonder on 31 Jul 2021
New migraine, spinal muscular atrophy drugs on PBS ease financial pain
1 August 2021 - New drugs for spinal muscular atrophy, migraine and high cholesterol are being added to the pharmaceutical benefits scheme easing the burden for thousands of patients.
From Sunday, new drugs listed on the Pharmaceutical Benefits Scheme will offer hope to some desperately sick children.
Australian children with spinal muscular atrophy types 1, 2 or 3a, aged 18 years or under will now have subsidised access to a drug called Evrysdi (Risdiplam), which is being listed on the PBS for the first time.
